Comments on: Tasigna(R) (nilotinib) Offers Potential Lifeline To Ph+ CML Patients Intolerant Or Resistant To Existing Therapies, Including Glivec(R) (imatinib)

Comments on: Tasigna(R) (nilotinib) Offers Potential Lifeline To Ph+ CML Patients Intolerant Or Resistant To Existing Therapies, Including Glivec(R) (imatinib) http://www.druginformations.org/medicine_news/2008/06/01/tasignar-nilotinib-offers-potential-lifeline-to-ph-cml-patients-intolerant-or-resistant-to-existing-therapies-including-glivecr-imatinib/ Your best medicine news resource Sat, 11 Feb 2012 17:06:27 +0000 http://wordpress.org/?v=2.1.2